Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology.

Schoonbeek MC, Gestraud P, Vernooij L, Boltjes A, Amo-Addae V, van Luik M, Del Nery E, Bellini A, Chua E, Swaak S, Looze EJ, Pietiäinen VM, Turunen LL, Saarela JS, Schueler J, Indersie E, Gürgen D, Scotlandi K, Eggert A, Bouarich-Bourimi R, Bourdeaut F, Zaidi S, Surdez D, Carcaboso ÁM, Geoerger B, Federico A, Kool M, Iddir Y, Saint-Charles A, Saberi-Ansari E, Cavalli F, Gopisetty A, Rief EM, Caron HN, Stancato L, Vassal G, Pfister S, Koster J, Eising S, van Hooff SR, van den Boogaard ML, Schleiermacher G, Molenaar JJ

Open source

DOI
10.1038/s41698-025-01266-0
Published
2026 Jan 10
Container
NPJ precision oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41698-025-01266-0,
  title = {Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology.},
  author = {Schoonbeek MC and Gestraud P and Vernooij L and Boltjes A and Amo-Addae V and van Luik M and Del Nery E and Bellini A and Chua E and Swaak S and Looze EJ and Pietiäinen VM and Turunen LL and Saarela JS and Schueler J and Indersie E and Gürgen D and Scotlandi K and Eggert A and Bouarich-Bourimi R and Bourdeaut F and Zaidi S and Surdez D and Carcaboso ÁM and Geoerger B and Federico A and Kool M and Iddir Y and Saint-Charles A and Saberi-Ansari E and Cavalli F and Gopisetty A and Rief EM and Caron HN and Stancato L and Vassal G and Pfister S and Koster J and Eising S and van Hooff SR and van den Boogaard ML and Schleiermacher G and Molenaar JJ},
  year = {2026},
  journal = {NPJ precision oncology},
  doi = {10.1038/s41698-025-01266-0},
  url = {https://doi.org/10.1038/s41698-025-01266-0}
}

RIS

TY  - JOUR
TI  - Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology.
AU  - Schoonbeek MC
AU  - Gestraud P
AU  - Vernooij L
AU  - Boltjes A
AU  - Amo-Addae V
AU  - van Luik M
AU  - Del Nery E
AU  - Bellini A
AU  - Chua E
AU  - Swaak S
AU  - Looze EJ
AU  - Pietiäinen VM
AU  - Turunen LL
AU  - Saarela JS
AU  - Schueler J
AU  - Indersie E
AU  - Gürgen D
AU  - Scotlandi K
AU  - Eggert A
AU  - Bouarich-Bourimi R
AU  - Bourdeaut F
AU  - Zaidi S
AU  - Surdez D
AU  - Carcaboso ÁM
AU  - Geoerger B
AU  - Federico A
AU  - Kool M
AU  - Iddir Y
AU  - Saint-Charles A
AU  - Saberi-Ansari E
AU  - Cavalli F
AU  - Gopisetty A
AU  - Rief EM
AU  - Caron HN
AU  - Stancato L
AU  - Vassal G
AU  - Pfister S
AU  - Koster J
AU  - Eising S
AU  - van Hooff SR
AU  - van den Boogaard ML
AU  - Schleiermacher G
AU  - Molenaar JJ
PY  - 2026
JO  - NPJ precision oncology
DO  - 10.1038/s41698-025-01266-0
UR  - https://doi.org/10.1038/s41698-025-01266-0
ER  - 

APA

MC, S., P, G., L, V., A, B., V, A., M, V. L., E, D. N., A, B., E, C., S, S., EJ, L., VM, P., LL, T., JS, S., J, S., E, I., D, G., K, S., A, E., R, B., F, B., S, Z., D, S., ÁM, C., B, G., A, F., M, K., Y, I., A, S., E, S., F, C., A, G., EM, R., HN, C., L, S., G, V., S, P., J, K., S, E., SR, V. H., ML, V. D. B., G, S., & JJ, M. (2026). Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology.. NPJ precision oncology. https://doi.org/10.1038/s41698-025-01266-0

Source records